Ximeceff DS Dry Syrup contains Cefixime 100mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ximeceff DS Dry Syrup is formulated as a dry powder for suspension, allowing accurate dosing in pediatric and adult patients who have difficulty swallowing tablets. The medication is generally well tolerated; however, common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and occasional hypersensitivity reactions. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Dosage should be adjusted based on the severity of infection, patient age, and renal function. It is essential to complete the full prescribed course to prevent the development of resistance. Caution is advised in patients with renal impairment, and concomitant use with nephrotoxic drugs should be monitored. Ximeceff DS Dry Syrup should be stored in a cool, dry place and reconstituted suspension should be used within the recommended time frame to maintain efficacy.